Nitrofurantoin Suspension
FDA Label NDC 69238-2512

31 label sections · Submitted to the FDA by Amneal Pharmaceuticals Ny Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Amneal Pharmaceuticals Ny Llc for the product Nitrofurantoin (NDC 69238-2512). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1 recommended dosage and administration in adult patients, 2.2 recommended dosage and administration in pediatric patients (1 month of age and older), 3 dosage forms and strengths, 4 contraindications, 5.1 hypersensitivity reactions, 5.2 pulmonary reactions, 5.3 hepatotoxicity, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.